Alchemab Therapeutics
Jenny Howell oversees project management at Alchemab and is responsible for managing the research and development portfolio and projects.
Prior to joining Alchemab, Jenny held strategic portfolio and project management roles at AstraZeneca, MedImmune, Alizyme Therapeutics, and GSK.
Jenny earned a BSc in Applied Chemistry from Northumbria University.
This person is not in any offices
Alchemab Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.